Dirix, LY; Takács, István; Jerusalem, G; Nikolinakos, P; Arkenau, HT; Forero-Torres, A; Boccia, R; Lippman, ME; Somer, R; Smakal, M; Emens, LA; Hrinczenko, B; Edenfield, W; Gurtler, J; von Heydebreck, A; Grote, HJ; Chin, K; Hamilton, EP
(2018)
PURPOSE: Agents targeting programmed death receptor 1 (PD-1) or its ligand (PD-L1) have shown antitumor activity in the treatment of metastatic breast cancer (MBC). The aim of this study was to assess the activity of ...